← Back to Search

Postoperative Hip Precautions for Osteoarthritis

N/A
Recruiting
Led By Brett Levine, MD, MS
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing a primary total hip arthroplasty via the posterior approach by participating attending surgeons at this institution
Index diagnosis of noninflammatory arthritis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks after surgery
Awards & highlights

Study Summary

This trial will help determine if hip precautions after surgery help prevent hip dislocation and improve patient satisfaction.

Who is the study for?
This trial is for patients with noninflammatory arthritis who are having their first total hip replacement through the posterior approach. They must understand and follow study procedures but can't join if they have allergies to materials used in the study or previous major surgeries on the affected joint.Check my eligibility
What is being tested?
The study is testing whether following 'hip precautions' after a hip replacement surgery affects dislocation rates, recovery of daily activities, patient satisfaction, and cost-effectiveness compared to not using these precautions.See study design
What are the potential side effects?
Since this trial compares lifestyle instructions rather than medications, traditional side effects aren't expected. However, there may be differences in comfort levels or mobility challenges between groups.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having my first total hip replacement surgery through the back of the hip by a surgeon from this hospital.
Select...
My arthritis is not caused by inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dislocation
Secondary outcome measures
Activities of Daily Living
Other outcome measures
Use of Assistive Devices After Surgery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: No Hip PrecautionsExperimental Treatment1 Intervention
Patients will not be prescribed hip precautions in the first 6 weeks after surgery. The hip precautions that will no longer be prescribed are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.
Group II: Hip PrecautionsActive Control1 Intervention
Patients will receive the following hip precautions: no hip flexion past 90º, no crossing the legs, and no twisting at the waist for the first six weeks after surgery.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
420 Previous Clinical Trials
162,249 Total Patients Enrolled
25 Trials studying Osteoarthritis
2,238 Patients Enrolled for Osteoarthritis
Brett Levine, MD, MS4.8237 ReviewsPrincipal Investigator - Assistant Professor
Rush University Medical Center
5Patient Review
I feel so lucky to have found Dr Levine and his team. They were able to help me through my surgery and recovery with such ease and care. I was originally drawn to him because he came highly recommended as a physician who worked with challenging cases, but what really won me over was his team's respect for my concerns and their dedication to keeping me well informed. I also loved the daily educational text support — it gave me a step-by-step guide of valuable information that was crucial for my successful recovery. With Dr Levine and his team, I know I'm in good hands for my next surgery.

Media Library

Hip Precautions Clinical Trial Eligibility Overview. Trial Name: NCT02686528 — N/A
Osteoarthritis Research Study Groups: No Hip Precautions, Hip Precautions
Osteoarthritis Clinical Trial 2023: Hip Precautions Highlights & Side Effects. Trial Name: NCT02686528 — N/A
Hip Precautions 2023 Treatment Timeline for Medical Study. Trial Name: NCT02686528 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants involved in this trial?

"Affirmative, the information on clinicaltrials.gov attests that this medical investigation is actively recruiting volunteers. This study was initially uploaded to the website on January 1st 2016 and has been recently amended on October 25th 2022. Currently 1000 participants need to be enrolled from a single trial site."

Answered by AI

Does this research project still have vacancies for participants?

"According to the particulars on clinicaltrials.gov, this scientific study is in a recruitment phase and requires new participants. The trial was initially publicized on January 1st 2016 with its most recent update occurring on October 25th 2022."

Answered by AI
~83 spots leftby Jan 2025